错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Inceptor binds to and directs insulin towards lysosomal degradation in β cells

  • Johanna Siehler,
  • Sara Bilekova,
  • Prisca Chapouton,
  • Alessandro Dema,
  • Pascal Albanese,
  • Sem Tamara,
  • Chirag Jain,
  • Michael Sterr,
  • Stephen J. Enos,
  • Chunguang Chen,
  • Chetna Malhotra,
  • Adrian Villalba,
  • Leopold Schomann,
  • Sreya Bhattacharya,
  • Jin Feng,
  • Melis Akgün Canan,
  • Federico Ribaudo,
  • Ansarullah,
  • Ingo Burtscher,
  • Christin Ahlbrecht,
  • Oliver Plettenburg,
  • Thomas Kurth,
  • Raphael Scharfmann,
  • Stephan Speier,
  • Richard A. Scheltema,
  • Heiko Lickert

摘要

Blunted first-phase insulin secretion and insulin deficiency are indicators of β cell dysfunction and diabetes manifestation. Therefore, insights into molecular mechanisms that regulate insulin homeostasis might provide entry sites to replenish insulin content and restore β cell function. Here, we identify the insulin inhibitory receptor (inceptor; encoded by the gene IIR/ELAPOR1) as an insulin-binding receptor that regulates insulin stores by lysosomal degradation. Using human induced pluripotent stem cell (SC)-derived islets, we show that IIR knockout (KO) results in enhanced SC β cell differentiation and survival. Strikingly, extended in vitro culture of IIR KO SC β cells leads to greatly increased insulin content and glucose-stimulated insulin secretion (GSIS). We find that inceptor localizes to clathrin-coated vesicles close to the plasma membrane and in the trans-Golgi network as well as in secretory granules, where it acts as a sorting receptor to direct proinsulin and insulin towards lysosomal degradation. Targeting inceptor using a monoclonal antibody increases proinsulin and insulin content and improves SC β cell GSIS. Altogether, our findings reveal the basic mechanisms of β cell insulin turnover and identify inceptor as an insulin degradation receptor.